QuidelOrtho Corp (QDEL)
38.96
-1.06
(-2.65%)
USD |
NASDAQ |
Nov 14, 16:00
38.94
-0.02
(-0.05%)
After-Hours: 20:00
QuidelOrtho Cash and Short Term Investments (Quarterly): 143.70M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 143.70M |
June 30, 2024 | 107.00M |
March 31, 2024 | 78.50M |
December 31, 2023 | 167.30M |
September 30, 2023 | 193.20M |
June 30, 2023 | 223.70M |
March 31, 2023 | 396.70M |
December 31, 2022 | 345.00M |
September 30, 2022 | 264.00M |
June 30, 2022 | 431.50M |
March 31, 2022 | 1.320B |
December 31, 2021 | 828.50M |
September 30, 2021 | 578.45M |
June 30, 2021 | 593.22M |
March 31, 2021 | 981.05M |
December 31, 2020 | 489.94M |
September 30, 2020 | 77.55M |
June 30, 2020 | 72.59M |
March 31, 2020 | 108.77M |
December 31, 2019 | 52.78M |
September 30, 2019 | 28.91M |
June 30, 2019 | 28.55M |
March 31, 2019 | 56.94M |
December 31, 2018 | 43.70M |
September 30, 2018 | 38.69M |
Date | Value |
---|---|
June 30, 2018 | 38.68M |
March 31, 2018 | 101.81M |
December 31, 2017 | 36.09M |
September 30, 2017 | 172.99M |
June 30, 2017 | 175.05M |
March 31, 2017 | 197.49M |
December 31, 2016 | 169.51M |
September 30, 2016 | 153.36M |
June 30, 2016 | 155.57M |
March 31, 2016 | 153.45M |
December 31, 2015 | 191.47M |
September 30, 2015 | 182.56M |
June 30, 2015 | 204.74M |
March 31, 2015 | 229.43M |
December 31, 2014 | 200.90M |
September 30, 2014 | 17.36M |
June 30, 2014 | 18.08M |
March 31, 2014 | 25.16M |
December 31, 2013 | 8.388M |
September 30, 2013 | 10.25M |
June 30, 2013 | 21.95M |
March 31, 2013 | 44.38M |
December 31, 2012 | 14.86M |
September 30, 2012 | 17.84M |
June 30, 2012 | 19.88M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
52.78M
Minimum
Dec 2019
1.320B
Maximum
Mar 2022
372.66M
Average
243.85M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Abbott Laboratories | 7.788B |
Becton Dickinson & Co | 2.162B |
Repligen Corp | 809.15M |
Perspective Therapeutics Inc | 292.87M |
Xtant Medical Holdings Inc | 5.379M |